The available information is in an Adobe PDF format. Please make sure you are using the latest version of Adobe Reader. To download Adobe Reader, please click on the link below.
- First Treatment for MPS IVA Approved
- Annual EveryLife Art Contest
- BioMarin Announces FDA Approval for VIMIZIM(TM) (elosulfase alfa) for the Treatment of Patients With Morquio A Syndrome
- BioMarin Announces Selection of NAGLU, BMN 250 for the Treatment of Sanfilippo B